Status:
UNKNOWN
Inflammatory Bowel Disease (IBD) and Covid-19 Infection
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Inflammatory Bowel Disease
Eligibility:
All Genders
18+ years
Brief Summary
Most of the inflammatory bowel disease (IBD: Crohn's disease and ulcerative colitis) in a tertiary expert Centre are on immunosuppressive and/or biological therapy. Theoretically, these treatments may...
Eligibility Criteria
Inclusion
- Patient over the age of 18 years
- IBD patients (Crohn's disease, ulcerative colitis, indeterminate colitis)
- Patient agreeing to participate in the study
Exclusion
- Patient unable to understand the study protocol or to answer simple anamnestic questions due to language barrier
- Patient under guardianship or trusteeship
- Patient under safeguard of justice
Key Trial Info
Start Date :
July 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 7 2021
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04492267
Start Date
July 7 2020
End Date
January 7 2021
Last Update
July 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Hépato-Gastroentérologie et Assistance Nutritive Hôpitaux Univesitaires de Strasbourg
Strasbourg, France, 67091